Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuliia Sereda

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Understanding Bladder Cancer Screening Limits Through Comparative Modeling: The Maximum Clinical Incidence Reduction (MCLIR) MethodologyHawre Jalal, Stella K Kang, Fernando Alarid-Escudero, et al.
European Urology Open Science|December 24, 2025
Bladder Cancer Burden in the USA: Population Scenarios for 2040Hawre Jalal, Stella K Kang, Fernando Alarid-Escudero, et al.
Blood Advances|February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALLKristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Blood Advances|February 11, 2026
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young AdultsAdam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Understanding Bladder Cancer Screening Limits Through Comparative Modeling: The Maximum Clinical Incidence Reduction (MCLIR) MethodologyHawre Jalal, Stella K Kang, Fernando Alarid-Escudero, et al.
European Urology Open Science|December 24, 2025
Bladder Cancer Burden in the USA: Population Scenarios for 2040Hawre Jalal, Stella K Kang, Fernando Alarid-Escudero, et al.
Blood Advances|February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALLKristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Blood Advances|February 11, 2026
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young AdultsAdam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.
Pageof 4